Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19

Although several considerations have been raised suggesting a beneficial effect of N-acetyl cysteine (NAC) for the treatment of severe acute respiratory syndrome coronavirus 2 infection, there is currently no clinical evidence that NAC truly prevents coronavirus disease 2019 (COVID-19), reduces the...

Descripción completa

Detalles Bibliográficos
Autores principales: Finsterer, Josef, Scorza, Fulvio A, Scorza, Carla A, Fiorini, Ana C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788215/
https://www.ncbi.nlm.nih.gov/pubmed/35117973
http://dx.doi.org/10.5501/wjv.v11.i1.82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788215/
https://www.ncbi.nlm.nih.gov/pubmed/35117973
http://dx.doi.org/10.5501/wjv.v11.i1.82

Ejemplares similares